MENACTRA Side Effects

6529542-X | Amnesia, Anxiety, Asthenia, Dizziness, Hallucination, Heart Rate Increased, Hypoaesthesia, Insomnia, Lethargy
on Dec 29, 2009 Female patient from UNITED STATES , 15 years of age, was diagnosed with immunisation, tuberculin test and was treated with Menactra (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, anxiety (What is anxiety?), asthenia, dizziness (What is dizziness?), hallucination, heart rate increased, hypoaesthesia, insomnia, lethargy. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ), HUMAN PAPILLOMAVIRUS VACCINE (View Human Papillomavirus Vaccine Review and Human Papillomavirus Vaccine Label ). Patient was hospitalized.

6503506-4 | Cough, Fatigue, Infectious Mononucleosis, Lyme Disease, Lymphadenitis, Lymphadenopathy, Oropharyngeal Pain, Pain In Jaw
Patient was taking Menactra (View Usage). Patient had the following side effects: cough, fatigue, infectious mononucleosis (What is infectious mononucleosis?), lyme disease, lymphadenitis, lymphadenopathy, oropharyngeal pain, pain in jaw on Dec 14, 2009 from UNITED STATES Additional patient health information: Female patient , 17 years of age, was diagnosed with immunisation, tuberculin test and. Menactra dosage: . During the same period patient was treated with TUBERSOL (Route: Subdermal) (View Tubersol Review and Tubersol Label ).

6460879-9 | Cough, Fatigue, Infectious Mononucleosis, Lyme Disease, Lymphadenitis, Lymphadenopathy, Oropharyngeal Pain, Pain In Jaw
Adverse event was reported on Nov 23, 2009 by a Female patient taking Menactra (View Usage) (Dosage: ) was diagnosed with immunisation, tuberculin test and. Location: UNITED STATES , 17 years of age, After Menactra was administered, patient had the following side effects: cough, fatigue, infectious mononucleosis (What is infectious mononucleosis?), lyme disease, lymphadenitis, lymphadenopathy, oropharyngeal pain, pain in jaw. During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ).

6442895-6 | Amnesia, Anxiety, Asthenia, Dizziness, Hallucination, Heart Rate Increased, Hypoaesthesia, Insomnia, Lethargy
on Nov 10, 2009 Female patient from UNITED STATES , 15 years of age, was diagnosed with immunisation, tuberculin test and was treated with Menactra (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, anxiety (What is anxiety?), asthenia, dizziness (What is dizziness?), hallucination, heart rate increased, hypoaesthesia, insomnia, lethargy. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ), HUMAN PAPILLOMAVIRUS VACCINE (View Human Papillomavirus Vaccine Review and Human Papillomavirus Vaccine Label ). Patient was hospitalized.


6387568-3 | Amnesia, Anxiety, Dizziness, Heart Rate Increased, Hypoaesthesia, Insomnia, Lethargy, Speech Disorder
on Sep 28, 2009 Female patient from UNITED STATES , 15 years of age, was diagnosed with immunisation, tuberculin test and was treated with Menactra (View Usage). Patient had the following side effects: amnesia, anxiety (What is anxiety?), dizziness (What is dizziness?), heart rate increased, hypoaesthesia, insomnia, lethargy, speech disorder. Menactra dosage: . During the same period patient was treated with TUBERCULIN NOS (View Tuberculin Nos Review and Tuberculin Nos Label ), HUMAN PAPILLOMAVIRUS VACCINE (View Human Papillomavirus Vaccine Review and Human Papillomavirus Vaccine Label ). Patient was hospitalized.

6248231-2 | Fatigue, Infectious Mononucleosis, Lyme Disease, Lymphadenitis, Lymphadenopathy
Patient was taking Menactra (View Usage). After Menactra was administered, patient had the following side effects: fatigue, infectious mononucleosis (What is infectious mononucleosis?), lyme disease, lymphadenitis, lymphadenopathy on Jun 19, 2009 from UNITED STATES Additional patient health information: Female patient , 17 years of age, was diagnosed with immunisation, tuberculin test and. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ).

6161087-1 | Areflexia, Dysarthria, Facial Paresis, Gait Disturbance, Guillain-barre Syndrome, Muscular Weakness, Neck Pain, Paraesthesia, Sensation Of Heaviness
Adverse event was reported on Apr 14, 2009 by a Male patient taking Menactra (View Usage) (Dosage: ) was diagnosed with immunisation, tuberculin test and. Location: UNITED STATES , 18 years of age, Patient experienced the following unwanted or unexpected effects: areflexia, dysarthria, facial paresis, gait disturbance, guillain-barre syndrome (What is guillain-barre syndrome?), muscular weakness, neck pain, paraesthesia, sensation of heaviness. During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ), DIFFERIN (View Differin Review and Differin Label ). Patient was hospitalized.

5811724-3 | Back Pain, Escherichia Urinary Tract Infection, Neutropenia, Pyrexia, Rash Pruritic, Viral Infection
on Jul 08, 2008 Female patient from UNITED STATES , child 11 years of age, weighting 115.3 lb, was diagnosed with urinary tract infection (What is urinary tract infection?), disease recurrence and was treated with Menactra (View Usage). Patient had the following side effects: back pain (What is back pain?), escherichia urinary tract infection, neutropenia, pyrexia, rash pruritic, viral infection (What is viral infection?). Menactra dosage: . During the same period patient was treated with CEFTIN (250mg Twice Per Day) (View Ceftin Review and Ceftin Label ), CEFZIL (500mg Twice Per Day) (View Cefzil Review and Cefzil Label ), ROCEPHIN (500mg Continuous) (View Rocephin Review and Rocephin Label ). Patient was hospitalized.

5801655-7 | Back Pain, Neutropenia, Pyrexia, Rash Pruritic, Urinary Tract Infection
on Jul 01, 2008 Female patient from UNITED STATES , child 11 years of age, weighting 115.3 lb, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Menactra (View Usage). After Menactra was administered, patient had the following side effects: back pain (What is back pain?), neutropenia, pyrexia, rash pruritic, urinary tract infection (What is urinary tract infection?). Menactra dosage: . During the same period patient was treated with CEFTIN (250mg Twice Per Day) (View Ceftin Review and Ceftin Label ), CEFZIL (500mg Twice Per Day) (View Cefzil Review and Cefzil Label ), ROCEPHIN (500mg Continuous) (View Rocephin Review and Rocephin Label ). Patient was hospitalized.

5799650-X | Syncope Vasovagal
Patient was taking Menactra (View Usage). Patient experienced the following unwanted or unexpected effects: syncope vasovagal on Jun 30, 2008 from UNITED STATES Additional patient health information: Male patient , 18 years of age, weighting 187.4 lb, was diagnosed with immunisation, tuberculin test and. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ), BOOSTRIX (View Boostrix Review and Boostrix Label ).

5793345-4 | Back Pain, Neutropenia, Pyrexia, Rash Pruritic, Urinary Tract Infection
Adverse event was reported on Jun 20, 2008 by a Female patient taking Menactra (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , child 11 years of age, weighting 115.3 lb, Patient had the following side effects: back pain (What is back pain?), neutropenia, pyrexia, rash pruritic, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with CEFTIN (250mg Twice Per Day) (View Ceftin Review and Ceftin Label ), CEFZIL (500mg Twice Per Day) (View Cefzil Review and Cefzil Label ), ROCEPHIN (500mg Continuous) (View Rocephin Review and Rocephin Label ). Patient was hospitalized.

5753109-4 | Syncope
on May 27, 2008 Male patient from UNITED STATES , 18 years of age, weighting 187.4 lb, was diagnosed with immunisation, tuberculin test and was treated with Menactra (View Usage). After Menactra was administered, patient had the following side effects: syncope. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ), BOOSTRIX (View Boostrix Review and Boostrix Label ).

5717708-8 | Syncope
on Apr 21, 2008 Male patient from UNITED STATES , 18 years of age, weighting 187.4 lb, was diagnosed with immunisation, tuberculin test and was treated with Menactra (View Usage). Patient experienced the following unwanted or unexpected effects: syncope. Menactra dosage: . During the same period patient was treated with TUBERCULIN PPD (View Tuberculin Ppd Review and Tuberculin Ppd Label ), BOOSTRIX (View Boostrix Review and Boostrix Label ).

5490483-0 | Areflexia, Dysarthria, Facial Paresis, Gait Disturbance, Guillain-barre Syndrome, Muscular Weakness, Neck Pain, Paraesthesia, Sensation Of Heaviness
Patient was taking Menactra (View Usage). Patient had the following side effects: areflexia, dysarthria, facial paresis, gait disturbance, guillain-barre syndrome (What is guillain-barre syndrome?), muscular weakness, neck pain, paraesthesia, sensation of heaviness on Oct 15, 2007 from UNITED STATES Additional patient health information: Male patient , 18 years of age, was diagnosed with immunisation, tuberculin test and. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ), DIFFERIN (View Differin Review and Differin Label ). Patient was hospitalized.

5296205-0 | Back Pain, Escherichia Urinary Tract Infection, Neutropenia, Pruritus, Pyrexia, Rash, Viral Infection
Adverse event was reported on Apr 12, 2007 by a Female patient taking Menactra (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), disease recurrence and. Location: UNITED STATES , child 11 years of age, weighting 115.3 lb, After Menactra was administered, patient had the following side effects: back pain (What is back pain?), escherichia urinary tract infection, neutropenia, pruritus, pyrexia, rash (What is rash?), viral infection (What is viral infection?). During the same period patient was treated with CEFTIN (250mg Twice Per Day) (View Ceftin Review and Ceftin Label ), CEFZIL (500mg Twice Per Day) (View Cefzil Review and Cefzil Label ), ROCEPHIN (500mg Continuous) (View Rocephin Review and Rocephin Label ). Patient was hospitalized.

5080991-9 | Abasia, Alanine Aminotransferase Increased, Anaemia, Arteriovenous Malformation, Blood Creatine Phosphokinase Increased, Blood Potassium Increased, Cerebral Haemorrhage, Factor Vii Deficiency, Fatigue
on May 30, 2006 Male patient from UNITED STATES , child 11 years of age, was diagnosed with immunisation, tuberculin test and was treated with Menactra (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, alanine aminotransferase increased, anaemia, arteriovenous malformation (What is arteriovenous malformation?), blood creatine phosphokinase increased, blood potassium increased, cerebral haemorrhage, factor vii deficiency, fatigue. Menactra dosage: . During the same period patient was treated with DECAVAC (View Decavac Review and Decavac Label ), TUBERSOL (View Tubersol Review and Tubersol Label ). Patient was hospitalized.

5070519-1 | Blood Glucose Increased, Haematocrit Decreased, Road Traffic Accident, Syncope Vasovagal
on May 03, 2006 Male patient from UNITED STATES , 18 years of age, was diagnosed with immunisation and was treated with Menactra (View Usage). Patient had the following side effects: blood glucose increased, haematocrit decreased, road traffic accident, syncope vasovagal. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ).

5056811-5 | Road Traffic Accident, Syncope
Patient was taking Menactra (View Usage). After Menactra was administered, patient had the following side effects: road traffic accident, syncope on May 03, 2006 from UNITED STATES Additional patient health information: Male patient , 18 years of age, was diagnosed with immunisation and. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ).

5047114-3 | Road Traffic Accident, Syncope
Adverse event was reported on May 03, 2006 by a Male patient taking Menactra (View Usage) (Dosage: ) was diagnosed with immunisation and. Location: UNITED STATES , 18 years of age, Patient experienced the following unwanted or unexpected effects: road traffic accident, syncope. During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ).

5019771-9 | Arteriovenous Malformation, Haemorrhage, Headache, Muscular Weakness, Vascular Rupture
on May 30, 2006 Male patient from UNITED STATES , child 12 years of age, was diagnosed with immunisation and was treated with Menactra (View Usage). Patient had the following side effects: arteriovenous malformation (What is arteriovenous malformation?), haemorrhage, headache (What is headache?), muscular weakness, vascular rupture. Menactra dosage: . During the same period patient was treated with DIPHTHERIA AND TETANUS TOXOIDS (View Diphtheria And Tetanus Toxoids Review and Diphtheria And Tetanus Toxoids Label ), TUBERCULIN PPD (View Tuberculin Ppd Review and Tuberculin Ppd Label ). Patient was hospitalized.

4997744-X | Road Traffic Accident, Syncope
on May 03, 2006 Male patient from UNITED STATES , 18 years of age, was diagnosed with immunisation and was treated with Menactra (View Usage). After Menactra was administered, patient had the following side effects: road traffic accident, syncope. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ).

4821424-4 | Injection Site Erythema, Injection Site Pruritus, Injection Site Swelling
Patient was taking Menactra (View Usage). Patient experienced the following unwanted or unexpected effects: injection site erythema, injection site pruritus, injection site swelling on Nov 04, 2005 from UNITED STATES Additional patient health information: Female patient , 17 years of age, . Menactra dosage: Injectable. During the same period patient was treated with MENOMUNE A/C/Y/W 135 (Injectable) (View Menomune-a/c/y/w-135 Review and Menomune-a/c/y/w-135 Label ).

4794874-2 | Areflexia, Asthenia, Difficulty In Walking, Dysarthria, Facial Paresis, Guillain-barre Syndrome, Neck Pain, Paraesthesia, Sensation Of Heaviness
Adverse event was reported on Jul 14, 2005 by a Male patient taking Menactra (View Usage) (Dosage: ) was diagnosed with immunisation, tuberculin test and. Location: UNITED STATES , 18 years of age, Patient had the following side effects: areflexia, asthenia, difficulty in walking, dysarthria, facial paresis, guillain-barre syndrome (What is guillain-barre syndrome?), neck pain, paraesthesia, sensation of heaviness. During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ). Patient was hospitalized.

4784312-8 | Difficulty In Walking, Dysarthria, Facial Paresis, Guillain-barre Syndrome, Neck Pain, Paraesthesia, Sensation Of Heaviness, Sensory Disturbance
on Jul 14, 2005 Male patient from UNITED STATES , 18 years of age, was diagnosed with immunisation, tuberculin test and was treated with Menactra (View Usage). After Menactra was administered, patient had the following side effects: difficulty in walking, dysarthria, facial paresis, guillain-barre syndrome (What is guillain-barre syndrome?), neck pain, paraesthesia, sensation of heaviness, sensory disturbance. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ). Patient was hospitalized.

4761297-1 | Difficulty In Walking, Dysarthria, Facial Paresis, Guillain-barre Syndrome, Neck Pain, Paraesthesia, Sensation Of Heaviness, Sensory Disturbance
on Jul 14, 2005 Male patient from UNITED STATES , 18 years of age, was diagnosed with immunisation, tuberculin test and was treated with Menactra (View Usage). Patient experienced the following unwanted or unexpected effects: difficulty in walking, dysarthria, facial paresis, guillain-barre syndrome (What is guillain-barre syndrome?), neck pain, paraesthesia, sensation of heaviness, sensory disturbance. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ). Patient was hospitalized.

4739060-7 | Difficulty In Walking, Dysarthria, Facial Paresis, Guillain-barre Syndrome, Neck Pain, Paraesthesia, Sensation Of Heaviness, Sensory Disturbance
Patient was taking Menactra (View Usage). Patient had the following side effects: difficulty in walking, dysarthria, facial paresis, guillain-barre syndrome (What is guillain-barre syndrome?), neck pain, paraesthesia, sensation of heaviness, sensory disturbance on Jul 14, 2005 from UNITED STATES Additional patient health information: Male patient , 18 years of age, was diagnosed with immunisation, tuberculin test and. Menactra dosage: . During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ). Patient was hospitalized.

4716456-0 | Dysarthria, Facial Paresis, Guillain-barre Syndrome, Paraesthesia
Adverse event was reported on Jul 14, 2005 by a Male patient taking Menactra (View Usage) (Dosage: ) was diagnosed with immunisation, tuberculin test and. Location: UNITED STATES , 18 years of age, After Menactra was administered, patient had the following side effects: dysarthria, facial paresis, guillain-barre syndrome (What is guillain-barre syndrome?), paraesthesia. During the same period patient was treated with TUBERSOL (View Tubersol Review and Tubersol Label ). Patient was hospitalized.